Global COVID Testing Kit Market Size, Share, and COVID-19 Impact Analysis, By Type (Immunoassay Test Strips, RT-PCR Assay Kits, and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global COVID Testing Kit Market Insights Forecasts to 2035

• The Global COVID Testing Kit Market Size Was Estimated at USD 80.70 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.20% from 2025 to 2035
• The Worldwide COVID Testing Kit Market Size is Expected to Reach USD 173.40 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

The global COVID testing kit market size was worth around USD 80.70 billion in 2024 and is predicted to grow to around USD 173.40 billion by 2035 with a compound annual growth rate (CAGR) of 7.20% from 2025 and 2035. The creation of portable or on-site test kits for real-time management, strong WHO recommendations to prioritize COVID-19 diagnostic testing, and the incorporation of cutting-edge technology and software solutions are the main factors driving the COVID testing kit market.

Market Overview

The global industry that produces, distributes, and uses diagnostic kits intended to identify the presence of SARS-CoV-2 is known as the COVID testing kit market. These kits, which serve diagnostic labs, hospitals, and home care settings, include RT-PCR assay kits, immunoassay test strips, and fast antigen testing. The COVID testing kit market focuses on innovation, accessibility, accuracy, government initiatives, new variations, home-based testing, regulatory clearances, competitive dynamics, and healthcare infrastructure to guarantee universal availability and efficient diagnosis. Growing knowledge of testing requirements and technology improvements presents substantial growth opportunities in the COVID testing kit market. The market is growing as a result of rising COVID-19 cases, government and private funding, and support for research and development. The growing number of emergency use authorizations for diagnostic kits and devices, as well as advancements and assistance from non-medical device/diagnostic firms, further stimulate the COVID testing kit market.  The rising need for additional COVID-19 testing kits and equipment due to the rising number of cases is fueling the COVID testing kit market.   

Report Coverage

This research report categorizes the COVID testing kit market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the COVID testing kit market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the COVID testing kit market. 

Driving Factors

The rise of new COVID variants, government testing regulations, and the ongoing focus on pandemic preparedness are some of the primary factors driving the market for COVID testing kits. Growth in the COVID testing kit market is mostly driven by the ongoing demand for effective and precise diagnostic tools following the COVID-19 pandemic. Developing and implementing novel, portable testing solutions is also helped by the increased focus on decentralized and point-of-care testing, particularly in rural and resource-constrained areas. One of the main factors propelling the COVID testing kit market's expansion is the rising need for COVID-19 testing.   

Restraining Factors  

The market for COVID testing kits is restricted by factors such as post-pandemic declines in demand, regulatory obstacles, high prices, supply chain interruptions, accuracy issues, competition, restricted accessibility, and decreased government funding that hinders COVID testing kit market.  

Market Segmentation

The COVID testing kit market share is classified into type and end user. 

• The RT-PCR assay kits segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the COVID testing kit market is divided into immunoassay test strips, RT-PCR assay kits, and others. Among these, the RT-PCR assay kits segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. A crucial component of initiatives to contain and manage the COVID-19 pandemic is the RT-PCR assay kits segment. The need for testing kits has skyrocketed globally due to the rapid spread of COVID-19. The primary factors for this are the excellent sensitivity and specificity of RT-PCR assay kits and their technological improvements.

• The hospitals & clinics segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the COVID testing kit market is divided into hospitals and clinics, diagnostic laboratories, and others. Among these, the hospitals & clinics segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The section on hospitals and clinics is a result of the widespread use of sophisticated diagnostic technologies by medical practitioners. Additionally, the government's growing support for hospitals is expected to fuel the hospital segment's expansion.    

Regional Segment Analysis of the COVID Testing Kit Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Europe is anticipated to hold the largest share of the COVID testing kit market over the predicted timeframe.

Europe is anticipated to hold the largest share of the COVID testing kit market over the predicted timeframe. The significant rise in the number of COVID-19 cases in the Europe region, the enormous need for RT-PCR and other diagnostic kits to contain the outbreak, and technological developments are to blame. The need for testing kits is rising in the region as a result of European nations and their governments concentrating on enhancing testing capacities to stop the COVID-19 pandemic. In addition, the COVID testing kit market in Germany had the most market share and was expanding at the fastest rate in the European Union. Moreover, the market for COVID testing kits in Spain accounted for a sizeable portion of the European market.     

Asia Pacific is expected to grow at a rapid CAGR in the COVID testing kit market during the forecast period. The rising number of COVID-19 cases in the Asia-Pacific area is a result of both public and commercial investment in research and development for accurate diagnosis. The Indian Department of Science and Technology (DST) declared that it would give around USD 26.42 million to a range of enterprises, startups, and scientific institutions to help them develop creative ways to combat the COVID-19 epidemic. These solutions include protection gear, other essential treatments, quick and precise diagnostic tools, and other treatment options.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the COVID testing kit market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Abbott
• GenMark
• QiagenBGI Group
• Siemens AG
• Danaher Corporation
• BioMérieux SA
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2022, the CoviEasy Self-Test Rapid Antigen test kit for COVID-19 was launched by Genes2Me in India. It is simple to use and provides results in ten minutes. This IVD device offers a high level of sensitivity and concordance with over 98% accuracy, supported by an AI-driven mobile app.
• In May 2022, In partnership with Genes2Me, Cipla launched the RT-Direct multiplex COVID-19 RT-PCR test kit in India.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the COVID testing kit market based on the below-mentioned segments:  

Global COVID Testing Kit Market, By Type

• Immunoassay Test Strips
• RT-PCR Assay Kits
• Others

Global COVID Testing Kit Market, By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Global COVID Testing Kit Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa